Alexander Semyonov took part in the Russia-Africa summit
On July 27-28, St. Petersburg hosted the Second Russia-Africa Summit, which touched upon all areas of mutual partnership. As part of the business program of the summit, Alexander Semyonov, President of Acticomp, took part in the discussion "Effective cooperation in the field of healthcare: medicines, innovations, technologies."
The following were also involved in the discussion: Minister of Health of the Russian Federation Mikhail Murashko, Minister of Health of the Republic of Uganda Jane Ruth Aseng, Minister of Health and Social Services of the Republic of Namibia Kalumbi Shangula, Deputy Head of the Federal Medical and Biological Agency Igor Borisevich, Deputy Minister of Industry and Trade of the Russian Federation Ekaterina Priezzheva, Chairman of the Board of Directors of BIOCAD JSC Dmitry Morozov.
The outlined course towards consolidating the efforts of Russia and Africa in the field of healthcare development and drug policy will help to form a long-term mutually beneficial partnership. First of all, we are talking about the exchange of medical technologies, scientific achievements and innovative developments that ensure uninterrupted access to citizens of Russia and the African continent of strategically important drugs and medical devices.
In his speech, Alexander Semyonov called for considering the course towards import independence of the Russian pharmaceutical industry, outlined in the Pharma-2030 strategy, as a time of opportunities. Cases received during the COVID-19 pandemic have clearly demonstrated that dependence on supplies from China and India has a negative impact on pharmaceutical production in Russia and other countries. It is necessary to build a policy for the production of full-cycle drugs within the country, as Europe did on the example of its international project - the company EuroAPI. He also suggested considering the idea of building full-cycle factories for several African countries.
Alexander Semyonov noted that in the Pharma-2030 strategy, one of the goals for manufacturers of active pharmaceutical ingredients (API) and full-cycle drugs is the development of export directions. “We could supply APIs, finished drugs and even standard samples to the countries of the African continent, but here it is important to synchronize GMP standards between our countries, think over logistical ways and payment methods. And, of course, the presence of a standardized system of government contacts from the relevant ministries of African states also plays a key role in this direction,” he stressed, answering the question of what measures to strengthen regulatory systems are necessary t